Skip to main content
Equibles

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in MYGN — Myriad Genetics Inc

CIK 1164508 BOSTON, MA
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,469,588
+$3,548,852 QoQ
Shares Held
782,765
+282.6% QoQ
Ownership
0.818%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 196 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,756,493,842 across 20 Diagnostics & Research names. MYGN ranks #17 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DHR
Danaher Corp /De/
 5,163,059 $983,459,478
2 IDXX
Idexx Laboratories Inc /De
 1,067,078 $561,752,542
3 TMO
Thermo Fisher Scientific Inc.
 1,007,394 $505,067,055
4 NTRA
Natera, Inc.
 1,503,706 $408,180,993
5 A
Agilent Technologies, Inc.
 1,844,954 $245,065,239
6 IQV
Iqvia Holdings Inc.
 1,250,053 $241,535,240
7 MEDP
Medpace Holdings, Inc.
 429,012 $227,200,465
8 MTD
Mettler Toledo International Inc/
 167,741 $214,290,804

All Filings in MYGN

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,469,588 782,765
2026-03-31 $920,736 204,608
2024-12-31 $2,098,480 153,062
2024-09-30 $4,863,943 177,581
2020-12-31 $361,079 18,264
2020-09-30 $6,966,202 534,218
2020-06-30 $9,559,620 843,000